Kasahara N - Search Results

1

Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression.

Perez OD, Logg CR, Hiraoka K, Diago O, Burnett R, Inagaki A, Jolson D, Amundson K, Buckley T, Lohse D, Lin A, Burrascano C, Ibanez C, Kasahara N, Gruber HE, Jolly DJ. Perez OD, et al. Among authors: kasahara n. Mol Ther. 2012 Sep;20(9):1689-1698. doi: 10.1038/mt.2012.83. Epub 2012 May 1. Mol Ther. 2012. PMID: 22547150 Free PMC article.

2

A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism.

Soifer H, Higo C, Logg CR, Jih LJ, Shichinohe T, Harboe-Schmidt E, Mitani K, Kasahara N. Soifer H, et al. Among authors: kasahara n. Mol Ther. 2002 May;5(5 Pt 1):599-608. doi: 10.1006/mthe.2002.0586. Mol Ther. 2002. PMID: 11991751 Free article.

3

Tissue-specific transcriptional targeting of a replication-competent retroviral vector.

Logg CR, Logg A, Matusik RJ, Bochner BH, Kasahara N. Logg CR, et al. Among authors: kasahara n. J Virol. 2002 Dec;76(24):12783-91. doi: 10.1128/jvi.76.24.12783-12791.2002. J Virol. 2002. PMID: 12438603 Free PMC article.

4

Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors.

Wang WJ, Tai CK, Kasahara N, Chen TC. Wang WJ, et al. Among authors: kasahara n. Hum Gene Ther. 2003 Jan 20;14(2):117-27. doi: 10.1089/104303403321070810. Hum Gene Ther. 2003. PMID: 12614563 Free PMC article.

5

Antibody-mediated targeting of replication-competent retroviral vectors.

Tai CK, Logg CR, Park JM, Anderson WF, Press MF, Kasahara N. Tai CK, et al. Among authors: kasahara n. Hum Gene Ther. 2003 May 20;14(8):789-802. doi: 10.1089/104303403765255174. Hum Gene Ther. 2003. PMID: 12804141

6

Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo.

Logg CR, Kasahara N. Logg CR, et al. Among authors: kasahara n. Methods Mol Biol. 2004;246:499-525. doi: 10.1385/1-59259-650-9:499. Methods Mol Biol. 2004. PMID: 14970613

7

Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.

Tai CK, Wang WJ, Chen TC, Kasahara N. Tai CK, et al. Among authors: kasahara n. Mol Ther. 2005 Nov;12(5):842-51. doi: 10.1016/j.ymthe.2005.03.017. Mol Ther. 2005. PMID: 16257382 Free PMC article.

8

Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.

Dalba C, Klatzmann D, Logg CR, Kasahara N. Dalba C, et al. Among authors: kasahara n. Curr Gene Ther. 2005 Dec;5(6):655-67. doi: 10.2174/156652305774964659. Curr Gene Ther. 2005. PMID: 16457654 Review.

9

Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector.

Hiraoka K, Kimura T, Logg CR, Kasahara N. Hiraoka K, et al. Among authors: kasahara n. Clin Cancer Res. 2006 Dec 1;12(23):7108-16. doi: 10.1158/1078-0432.CCR-06-1452. Clin Cancer Res. 2006. PMID: 17145835 Free PMC article.

10

Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.

Dalba C, Bellier B, Kasahara N, Klatzmann D. Dalba C, et al. Among authors: kasahara n. Mol Ther. 2007 Mar;15(3):457-66. doi: 10.1038/sj.mt.6300054. Epub 2007 Jan 23. Mol Ther. 2007. PMID: 17245356 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters